Nxera Pharma Co (Nxera Pharma Co) Total Assets : $1,091.79 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co Total Assets?

Nxera Pharma Co's Total Assets for the quarter that ended in Dec. 2023 was $1,091.79 Mil.

During the past 12 months, Nxera Pharma Co's average Total Assets Growth Rate was 228.10% per year. During the past 3 years, the average Total Assets Growth Rate was 43.50% per year. During the past 5 years, the average Total Assets Growth Rate was 12.50% per year. During the past 10 years, the average Total Assets Growth Rate was 20.00% per year.

During the past 13 years, Nxera Pharma Co's highest 3-Year average Total Assets Growth Rate was 309.40%. The lowest was -17.60%. And the median was -0.10%.

Total Assets is connected with ROA %. Nxera Pharma Co's annualized ROA % for the quarter that ended in Dec. 2023 was -0.55%. Total Assets is also linked to Revenue through Asset Turnover. Nxera Pharma Co's Asset Turnover for the quarter that ended in Dec. 2023 was 0.05.

Nxera Pharma Co Total Assets Historical Data

The historical data trend for Nxera Pharma Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Total Assets Chart

Nxera Pharma Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

519.52

736.69

851.99

736.89

1,091.79

Nxera Pharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															736.89	738.56	736.17	1,010.78	1,091.79

Nxera Pharma Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Nxera Pharma Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	464.018	+	627.775
	=	1,091.79

Nxera Pharma Co's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	464.018	+	627.775
	=	1,091.79

Nxera Pharma Co (OTCPK:SOLTF) Total Assets Explanation

Total Assets is connected with ROA %.

Nxera Pharma Co's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-5.78	/	( (1010.782	+	1091.793)	/ 2 )
	=	-5.78	/	1051.2875
	=	-0.55 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Nxera Pharma Co's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	50.645	/	( (1010.782	+	1091.793)	/ 2 )
=	50.645	/	1051.2875
=	0.05

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Nxera Pharma Co Total Assets Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co (Nxera Pharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

4565:Japan JSS:Germany

Address

2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083

Website

http://www.sosei.com

Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.